发明名称 BICYCLIC HETEROCYCLIC DERIVATIVE OR SALT THEREOF
摘要 <p>[PROBLEMS] To provide a compound which can be used as a therapeutic agent for a disease in which an EP1 receptor is involved, particularly a lower urinary tract disease such as pollakiuria/urinary urgency and incontinence associated with overactive bladder, cystitis, interstitial cystitis and prostatitis. [MEANS FOR SOLVING PROBLEMS] It is found that a bicyclic heterocyclic derivative in which benzene rings are fused or a salt thereof has a potent EP1 receptor-antagonistic effect. The bicyclic heterocyclic derivative or salt thereof can be used as a therapeutic agent for a disease in which an EP1 receptor is involved, particularly a lower urinary tract disease such as pollakiuria/urinary urgency and incontinence associated with overactive bladder, cystitis, interstitial cystitis and prostatitis.</p>
申请公布号 WO2006121097(A1) 申请公布日期 2006.11.16
申请号 WO2006JP309447 申请日期 2006.05.11
申请人 HIRANO, YUSUKE;WATANABE, TORU;ASTELLAS PHARMA INC.;KUBOTA, HIDEKI;TSUKAMOTO, ISSEI;SUZUKI, DAISUKE;KOSHIO, HIROYUKI;KAMIJO, KAZUNORI;OHNUKI, KEI;KATO, KOJI;FUKUDA, YUTA 发明人 KUBOTA, HIDEKI;TSUKAMOTO, ISSEI;SUZUKI, DAISUKE;KOSHIO, HIROYUKI;KAMIJO, KAZUNORI;OHNUKI, KEI;KATO, KOJI;FUKUDA, YUTA;HIRANO, YUSUKE;WATANABE, TORU
分类号 C07D307/79;A61K31/343;A61K31/352;A61K31/357;A61K31/36;A61K31/381;A61K31/4025;A61K31/427;A61K31/443;A61K31/5377;A61P13/02;A61P13/10;A61P29/02;A61P35/00;A61P43/00;C07D307/82;C07D405/12;C07D405/14;C07D407/12;C07D407/14;C07D409/12;C07D417/12 主分类号 C07D307/79
代理机构 代理人
主权项
地址